Translation of a Personalized Genetic Medicine Vector Production System

Mediphage Bioceuticals aims to leverage its DNA ministring platform for personalized genetic medicine. Mediphage Bioceuticals Inc. greatly appreciate Mitacs Accelerate program in providing support to (1) validate msDNA for gene delivery by carrying out a two-phase study, (2) develop and validate phage display libraries for the specific targeting and delivery to target host cells, and (3) determine potential targets for gene therapy in the treatment of Alzheimer’s disease with examination of potential negative effects of bacteriophage vector platforms. The research efforts in these key areas will enable Mediphage Bioceuticals to further advance genetic medicine.

Faculty Supervisor:

Shawn Wettig

Student:

Partner:

Mediphage Bioceuticals Inc

Discipline:

Life Sciences

Sector:

Manufacturing; Professional, scientific and technical services

University:

University of Waterloo

Program: